G0 Cell Unit Researchers

(Left to right) Prof. Mitsuhiro Yanagida, technician Orie Arakawa, and Dr. Norihiko Nakazawa of the G0 Cell Unit authored a paper on the enzyme DNA topoisomerase II (topo II) a critical target for cancer therapy. Their experiments, conducted in yeast, revealed core mechanisms of topo II that could be exploited in future clinical studies.   

(Left to right) Prof. Mitsuhiro Yanagida, technician Orie Arakawa, and Dr. Norihiko Nakazawa of the G0 Cell Unit authored a paper on the enzyme DNA topoisomerase II (topo II) a critical target for cancer therapy. Their experiments, conducted in yeast, revealed core mechanisms of topo II that could be exploited in future clinical studies.   

Date:
31 January 2019
Share on: